A rare paraneoplastic syndrome causing weakness, pain and low serum phosphorous
FGF-23 paraneoplastic syndrome
DOI:
https://doi.org/10.17161/rrnmf.v3i1.15850Keywords:
FGF-23, paraneoplastic, hypophosphatemia, myalgia, myopathyAbstract
N/A
Metrics
Downloads
References
Florenzano P, Gafni RI, Collins MT. Tumor-induced osteomalacia. Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.PMID: 29021995
González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P et al., Osteoporos Int. 2017 Jul;28(7):2187-2193. doi: 10.1007/s00198-017-4007-2. Epub 2017 Mar 25.Pub. Med. PMID: 28341900
Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O. et al., Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 2012 Sep;27(9):1967-75. doi: 10.1002/jbmr.1642.PMID: 22532501
Li, X . The FGF metabolic axis. Front Med. 2019 Oct;13(5):511-530. doi: 10.1007/s11684-019-0711-y. Epub 2019 Sep 7. Pub.Med PMID: 31495905
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT Tumor induced osteomalacia. Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5. Pub.Med PMID: 32504138
Savva C, Adhikaree J, Madhusudan S, Chokkalingam K. Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature. J Diabetes Metab Disord. 2019 Mar 22;18(1):267-272. doi: 10.1007/s40200-019-00398-y. eCollection 2019 Jun.PMID: 31275898
Lin HA, Shih SR, Tseng YT, Chen CH, Chiu WY, Hsu CY, et al., Ovarian cancer-related hypophosphatemic osteomalacia--a case report J Clin Endocrinol Metab. 2014 Dec;99(12):4403-7. doi: 10.1210/jc.2014-2120.PMID: 25181387
Sauder A, Wiernek S, Dai X, Pereira R, Yudd M, Patel C et al., FGF23-Associated Tumor-Induced Osteomalacia in a Patient With Small Cell Carcinoma: A Case Report and Regulatory Mechanism Study. Int J Surg Pathol. 2016 Apr;24(2):116-20. doi: 10.1177/1066896915617828. Epub 2015 Nov 25.PMID: 26612848
Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T. et al., Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004 Feb;113(4):561-8. doi: 10.1172/JCI19081.PMID: 14966565
Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to it clinical consequences and management. Nat Clin Pract Nephrol. 2006 Mar;2(3):136-48. doi: 10.1038/ncpneph0124. Pub.Med PMID: 16932412
Efstratiadis G, Voulgaridou A, Nikiforou D, Kyventidis A, Kourkouni E, Vergoulas G. Rhabdomyolusis updated Hippokratia. 2007 Jul;11(3):129-37PubMed PMID: 19582207
Singhal PC, Kumar A, Desroches L, Gibbons N, Mattana J. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med. 1992 May;92(5):458-64. doi: 10.1016/0002-9343(92)90740-3.PMID: 1580292
Allen DG, Trajanovska S. The multiple roles of phosphate in muscle fatigue. Front Physiol. 2012 Dec 11;3:463. doi: 10.3389/fphys.2012.00463. eCollection 2012. Pub.Med PMID: 23248600
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R et al., Burosumab for the Treatment of Tumor-Induced Osteomalacia J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.PMID: 33338281
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Jeffrey Elliott MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
